Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

GNPS-Cystic Fibrosis Lung Tissue Patient1

ABSTRACT: Left human lung associated with cystic fibrosis was sectioned in to small cubes and analyzed by sequencing and mass spectrometry

INSTRUMENT(S): maXis

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Pieter C Dorrestein

PROVIDER: MSV000079652 | GNPS | Fri Apr 15 17:09:00 BST 2016

REPOSITORIES: GNPS

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

GNPS-Cystic Fibrosis_Human lung tissue

Project description:This data was collected on lung tissue associated with cystic fibrosis from 3 patients

2015-12-01 | MSV000079398 | GNPS

human lung metagenome

Project description:Human cystic fibrosis lung

| PRJNA288589 | ENA

human lung metagenome

Project description:Cystic Fibrosis Lung Metagenome

| PRJNA232392 | ENA

human lung metagenome

Project description:Cystic fibrosis lung infections Metagenome

| PRJNA257190 | ENA

human lung metagenome

Project description:Cystic fibrosis lung Targeted Locus (Loci)

| PRJNA271691 | ENA

Proteome analysis of lung, lung-derived leukocytes and PBMCs in a pig model for cystic fibrosis.

Project description:In Cystic Fibrosis (CF) patients, cycles of infection and inflammation lead to fatal lung damage. Here, we made use of a CF pig model to investigate proteome alterations in lung, lung-derived leukocytes and PBMCs.

2025-02-21 | PXD055249 | Pride

human lung metagenome

Project description:Viral and Microbial Cystic Fibrosis Lung Metagenome

| PRJNA71831 | ENA

human lung metagenome

Project description:human lung metagenome targeted loci cystic fibrosis

| PRJNA480715 | ENA

human lung metagenome

Project description:Viruses from cystic fibrosis lung tissue Metagenome

| PRJNA66313 | ENA

ARRA - NHLBI Lung Cohorts Sequencing Project

Project description:The major goal of this project is to apply second generation resequencing technology to identify disease causing variants influencing pediatric and adult lung diseases in a collection of two longitudinal population cohorts of cystic fibrosis patients that have been well characterized for a comprehensive set of clinical traits. In Phase I, exome sequencing was performed on 43 cystic fibrosis patients with early Pa infection and 48 cystic fibrosis patients with late Pa infection to identify variants influencing the time to onset of Pa infection. In Phase II, additional exomes were added to the study, to reach a total of 91 individuals with early Pa infection and 96 with late Pa infection. The majority of the 340 subjects of Phase II do not have a Pa infection phenotype, but instead have a pulmonary function phenotype (121 severe vs. 124 mild impairment) as determined by the survival corrected Kulich FEV percentile of Corey et al. A small minority have intermediate phenotypes and/or show severe decline in lung function during childhood.

| phs000254 | dbGaP

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data